gefitinib has been researched along with su 5402 in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (su 5402) | Trials (su 5402) | Recent Studies (post-2010) (su 5402) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 191 | 0 | 77 |
| Protein | Taxonomy | gefitinib (IC50) | su 5402 (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.1867 | |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | 0.2675 | |
| Fibroblast growth factor receptor 1 | Homo sapiens (human) | 2.0262 | |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | 0.1867 | |
| Fibroblast growth factor receptor 1 | Mus musculus (house mouse) | 10 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.1136 | |
| Vascular endothelial growth factor receptor 1 | Mus musculus (house mouse) | 0.4 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kwan, W; Liu, S; Lubieniecka, JM; Nielsen, TO; Terry, J | 1 |
1 other study(ies) available for gefitinib and su 5402
| Article | Year |
|---|---|
Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin prevents synovial sarcoma proliferation via apoptosis in in vitro models.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Benzamides; Benzoquinones; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; ErbB Receptors; Flow Cytometry; Gefitinib; HSP90 Heat-Shock Proteins; Humans; Imatinib Mesylate; Immunoblotting; Immunohistochemistry; In Situ Hybridization, Fluorescence; In Vitro Techniques; Inhibitory Concentration 50; Lactams, Macrocyclic; Piperazines; Prognosis; Pyrimidines; Pyrroles; Quinazolines; Rifabutin; Sarcoma, Synovial; Trastuzumab | 2005 |